Crossref
Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing
Advances in Molecular Pathology · 2018
DOI: 10.1016/j.yamp.2018.06.008 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advances in Molecular Pathology, 2018. Verfasst von Larisa H. Cavallari und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: NHGRI, NCATS, NIH/NHGRI.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- NHGRI
- NCATS
- NIH/NHGRI
- Indiana University Health – Indiana University School of Medicine Strategic Research Initiative
- Indiana University School of Medicine Pharmacogenomics Laboratory
Zitieren
APA
Cavallari, L. H., & Pratt, V. M. (2018). Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing. Advances in Molecular Pathology. https://doi.org/10.1016/j.yamp.2018.06.008
Vancouver
Cavallari LH, Pratt VM. Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing. Advances in Molecular Pathology. 2018. doi:10.1016/j.yamp.2018.06.008
BibTeX
@article{Cavallari2018,
author = {Cavallari, Larisa H. and Pratt, Victoria M.},
title = {Building Evidence for Clinical Use of Pharmacogenomics and Reimbursement for Testing},
journal = {Advances in Molecular Pathology},
year = {2018},
doi = {10.1016/j.yamp.2018.06.008}
}
EUVIMED